When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

   The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca , [ 33 ] [ 34 ] [ 35 ] using as a vector the modified ...

3. COVID-19 vaccine clinical research - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccine_clinical...

   One study indicated that the Oxford–AstraZeneca COVID-19 vaccine had an efficacy of 42–89% against Alpha, versus 71–91% against other variants. [ 459 ] [ unreliable medical source? Preliminary data from a clinical trial indicates that the Novavax vaccine is ~96% effective for symptoms against the original variant and ~86% against Alpha.

4. AstraZeneca-Oxford vaccine up to 90% effective against ...

   www.aol.com/astrazeneca-oxford-vaccine-90...

   An experimental coronavirus vaccine developed by Oxford University and drug manufacturer AstraZeneca appears to be up to 90% effective, the two partners announced Monday. AstraZeneca, whose shots ...

5. List of COVID-19 vaccine authorizations - Wikipedia

   en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

   National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...

6. U.S. trial determines Oxford COVID-19 vaccine is safe - AOL

   www.aol.com/news/astrazeneca-oxford-covid-19...

   AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, the company said on ...

7. AstraZeneca's COVID-19 shot shown to work longer-term - AOL

   www.aol.com/news/astrazeneca-antibody-drug-works...

   The latest results from the longer-term follow-ups potentially position AstraZeneca, like rival Pfizer as a future supplier of both COVID-19 vaccines and treatments, with AstraZeneca having said ...

8. History of COVID-19 vaccine development - Wikipedia

   en.wikipedia.org/wiki/History_of_COVID-19...

   [3] [45] [7] The collaboration of the University of Oxford with AstraZeneca (a global pharmaceutical company based in the UK) raised concerns about price and sharing of eventual profits from international vaccine sales, arising from whether the British government and university as public partners had commercialization rights. [8]

9. Oxford Covid-19 vaccine has similar effect against UK variant ...

   www.aol.com/oxford-covid-19-vaccine-similar...

   The study also suggests the jab results in a reduction in the duration of shedding and viral load, which may translate into reduced transmission.